米多君联合白蛋白治疗难治性腹水的协同作用 - Suppr

Midodrine with albumin synergy in refractory ascites management.

作者信息

Li Junzhen, Wu Yingjie

机构信息

Digestive Medical Center, The Seventh Affiliated Hospital, Sun Yat-Sen University, No. 628 Zhenyuan Road, Guangming New District, Shenzhen, 518107, Guangdong Province, China.

出版信息

Hepatol Int. 2025 Aug 13. doi: 10.1007/s12072-025-10892-6.

DOI:10.1007/s12072-025-10892-6

PMID:40802018

Abstract

摘要

相似文献

Midodrine with albumin synergy in refractory ascites management.米多君联合白蛋白治疗难治性腹水的协同作用

Hepatol Int. 2025 Aug 13. doi: 10.1007/s12072-025-10892-6.

Addition of midodrine to albumin reduces the incidence of complications of large-volume paracentesis: an RCT comparing midodrine, terlipressin, and albumin.在白蛋白中添加米多君可降低大量腹腔穿刺术并发症的发生率：一项比较米多君、特利加压素和白蛋白的随机对照试验。

Hepatol Int. 2025 Jul 4. doi: 10.1007/s12072-025-10841-3.

Effects of midodrine in patients with ascites due to cirrhosis: Systematic review and meta-analysis.米多君对肝硬化腹水患者的影响：系统评价与荟萃分析。

J Dig Dis. 2016 Jan;17(1):11-9. doi: 10.1111/1751-2980.12304.

Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: results of a pilot study.口服米多君与白蛋白输注对接受大量腹腔穿刺放液术的肝硬化难治性腹水患者的疗效相当：一项初步研究的结果

Eur J Gastroenterol Hepatol. 2019 Mar;31(3):345-351. doi: 10.1097/MEG.0000000000001277.

The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis.奥曲肽和米多君联合治疗并不优于白蛋白预防大量腹腔穿刺放液后腹水复发。

Clin Gastroenterol Hepatol. 2012 Oct;10(10):1169-75. doi: 10.1016/j.cgh.2012.06.027. Epub 2012 Jul 16.

Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.米多君与白蛋白预防肝硬化患者腹水穿刺诱导性循环功能障碍的比较：一项随机初步研究。

J Clin Gastroenterol. 2014 Feb;48(2):184-8. doi: 10.1097/MCG.0b013e31829ae376.

Commentary on "Addition of midodrine to albumin reduces the incidence of complications of large‑volume paracentesis: an RCT comparing midodrine, terlipressin, and albumin" : Midodrine-albumin: democratizing care for refractory ascites in resource-limited settings.关于“米多君联合白蛋白可降低大量腹腔穿刺术并发症的发生率：一项比较米多君、特利加压素和白蛋白的随机对照试验”的评论：米多君联合白蛋白：在资源有限的环境中普及难治性腹水的治疗

Hepatol Int. 2025 Jul 25. doi: 10.1007/s12072-025-10881-9.

The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study.米多君、长效奥曲肽和白蛋白治疗1个月对难治性腹水的影响：一项初步研究。

Liver Int. 2009 Feb;29(2):169-74. doi: 10.1111/j.1478-3231.2008.01778.x. Epub 2008 May 19.

Midodrine and albumin versus albumin alone for the secondary prophylaxis of acute kidney injury in a patient with cirrhosis and ascites.米多君和白蛋白与单独使用白蛋白相比，用于肝硬化和腹水患者急性肾损伤的二级预防。

Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e499-e504. doi: 10.1097/MEG.0000000000002154.

Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.预防腹腔穿刺术引起的循环功能障碍：米多君与白蛋白对比。一项随机试点研究。

Liver Int. 2008 Aug;28(7):1019-25. doi: 10.1111/j.1478-3231.2008.01734.x. Epub 2008 Apr 11.

本文引用的文献

Hepatol Int. 2025 Jul 4. doi: 10.1007/s12072-025-10841-3.

Effect of midodrine on HVPG in advanced chronic liver disease and acute-on-chronic liver failure-A pilot study.米多君对晚期慢性肝病和慢加急性肝衰竭患者 HVPG 的影响：一项初步研究。

Liver Int. 2024 Oct;44(10):2714-2723. doi: 10.1111/liv.16033. Epub 2024 Jul 24.

Midodrine plus propranolol versus propranolol alone in preventing first bleed in patients with cirrhosis and severe ascites: a randomized controlled trial.米多君联合普萘洛尔与单用普萘洛尔预防肝硬化伴大量腹水患者首次出血的随机对照试验。

Hepatol Int. 2024 Aug;18(4):1261-1270. doi: 10.1007/s12072-024-10687-1. Epub 2024 May 10.

Eur J Gastroenterol Hepatol. 2019 Mar;31(3):345-351. doi: 10.1097/MEG.0000000000001277.

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.失代偿期肝硬化患者长期白蛋白治疗（ANSWER）：一项开放标签随机试验。

Lancet. 2018 Jun 16;391(10138):2417-2429. doi: 10.1016/S0140-6736(18)30840-7. Epub 2018 Jun 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Midodrine with albumin synergy in refractory ascites management.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献